Social media for healthcare professionals in oncology: results from a cross-sectional survey conducted across eight countries in Asia, Latin America, and the Middle East

Aims: Guidance and regulation for the use of social media (SM) by healthcare professionals (HCPs) is lacking in some parts of the world. This paper explores the significance and barriers of SM in oncology care in regions beyond Europe and North America. Methods: A cross-sectional survey facilitated by Sermo to explore the use of SM among oncologists in Argentina, Brazil, India, Mexico, Saudi Arabia, Taiwan, Türkiye, and the United Arab Emirates was conducted between 14 June 2023 and 28 June 2023. A panel discussion involving seven digital opinion leaders (DOLs) was also held. Results: Of 340 respondents, the survey found strong support for SM in public and HCP education with most preferring mobile phones and 88% accessing SM in their free time. SM has an average-to-great impact on the prescribing habits of 52% of respondents. Sixty-four percent of respondents are concerned about potential conflicts of interest with SM. The panel developed a framework of recommendations providing navigational aids for key information, verifying sources to avoid misinformation, disclosing conflicts of interests, and creating visual and bite-sized content. Conclusion: Opportunities exist to enhance SM use in regions beyond Europe and North America. DOLs in oncology can enhance SM content quality.